Cardiovascular History and Hemodynamic Complications After Intubation in ICU

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Strasbourg, France

About this trial

This retrospective single-center observational study aims to evaluate the association between a history of cardiovascular disease and the occurrence of severe hemodynamic complications within 30 minutes after intubation in adult patients admitted to the intensive care unit. Cardiovascular history includes ischemic, arrhythmic, dilated or valvular heart disease, pulmonary hypertension, and systemic hypertension. Severe hemodynamic complications include severe hypotension, initiation or increase of norepinephrine, fluid resuscitation for hemodynamic instability, or cardiac arrest.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient aged 18 years or older

Patient hospitalized in intensive care unit between 01/01/2024 and 30/09/2025

Patient requiring intubation in intensive care unit

Absence of documented opposition to data reuse for research

Disqualifiers

Patient intubated for cardiac arrest

Patient intubated outside intensive care unit

Patient intubated under awake fiberoptic technique

Patient under legal protection (guardianship or curatorship)

Trial population

Adult patients admitted to the intensive care unit at Strasbourg University Hospital who required intubation during the study period.

Trial design

Design model

Case-only

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Severe hemodynamic complication after intubation

Occurrence of at least one severe hemodynamic complication within 30 minutes after intubation, including severe hypotension, catecholamine initiation or increase, fluid resuscitation, or cardiac arrest.

Time frame
Within 30 minutes after intubation

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.